The Lancet Infectious Diseases
Volume 11, Issue 6, 2011, Pages 418-419

Is screening immigrants for latent tuberculosis cost-effective? (Letter)

Mandalakas A.M.* , Menzies D.
  • a Department of Pediatrics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106-7292, United States, Department of Paediatrics and Child Health, Desmond Tutu TB Centre Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • b Respiratory and Epidemiology Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, QC, Canada

Abstract

[No abstract available]

Author Keywords

[No Keywords available]

Index Keywords

immigrant mass screening Letter human interferon gamma release assay priority journal Great Britain patient safety Humans Emigrants and Immigrants latent tuberculosis sensitivity and specificity Incidence tuberculin test isoniazid United Kingdom tuberculosis control chemoprophylaxis rifampicin cost-benefit analysis cost effectiveness analysis
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956258329&doi=10.1016%2fS1473-3099%2811%2970102-5&partnerID=40&md5=114106ce24f26bf0b2f420b633df3235
DOI: 10.1016/S1473-3099(11)70102-5
ISSN: 14733099
Cited by: 12
Original Language: English